Understanding Lecanemab: A Breakthrough in Alzheimer's Treatment
Dr. Jason Karlawish from Penn Medicine's Penn Memory Center discusses the groundbreaking Alzheimer's drug lecanemab. In this informative video, Dr. Karlawish explains:
The significance of lecanemab in slowing down Alzheimer's progression
How lecanemab works by targeting beta-amyloid plaques
The process of determining if lecanemab is right for a patient
Potential side effects and safety considerations
The importance of cardiovascular health in reducing dementia risk
Dr. Karlawish also addresses common concerns about Alzheimer's diagnosis and emphasizes the value of early detection and treatment. Learn about the latest advancements in Alzheimer's care and how Penn Medicine is at the forefront of this revolutionary treatment.
#pennmedicine
